Radiomics response signature for identification of metastatic colorectal cancer sensitive to therapies targeting EGFR pathway

L Dercle, L Lu, LH Schwartz, M Qian… - JNCI: Journal of the …, 2020 - academic.oup.com
Background The authors sought to forecast survival and enhance treatment decisions for
patients with liver metastatic colorectal cancer by using on-treatment radiomics signature to …
被引用次数：107 相关文章

Radiomics Response Signature for Identification of Metastatic Colorectal Cancer Sensitive to Therapies Targeting EGFR Pathway

L Dercle, L Lu, LH Schwartz, M Qian… - Journal of the …, 2020 - pubmed.ncbi.nlm.nih.gov
Background The authors sought to forecast survival and enhance treatment decisions for
patients with liver metastatic colorectal cancer by using on-treatment radiomics signature to …

Radiomics Response Signature for Identification of Metastatic Colorectal Cancer Sensitive to Therapies Targeting EGFR Pathway.

L Dercle, L Lu, LH Schwartz, M Qian… - Journal of the …, 2020 - europepmc.org
Background The authors sought to forecast survival and enhance treatment decisions for
patients with liver metastatic colorectal cancer by using on-treatment radiomics signature to …
[PDF] uclouvain.be

[PDF][PDF] Radiomics Response Signature for Identification of Metastatic Colorectal Cancer Sensitive to Therapies Targeting EGFR Pathway

L Dercle, L Lu, LH Schwartz, M Qian - 2020 - dial.uclouvain.be
Background: The authors sought to forecast survival and enhance treatment decisions for
patients with liver metastatic colorectal cancer by using on-treatment radiomics signature to …

Radiomics Response Signature for Identification of Metastatic Colorectal Cancer Sensitive to Therapies Targeting EGFR Pathway

L Dercle, L Lu, LH Schwartz, M Qian… - JNCI: Journal of the …, 2020 - academic.oup.com
Background The authors sought to forecast survival and enhance treatment decisions for
patients with liver metastatic colorectal cancer by using on-treatment radiomics signature to …
[HTML] nih.gov

[HTML][HTML] Radiomics Response Signature for Identification of Metastatic Colorectal Cancer Sensitive to Therapies Targeting EGFR Pathway

L Dercle, L Lu, LH Schwartz, M Qian… - JNCI Journal of the …, 2020 - ncbi.nlm.nih.gov
Background The authors sought to forecast survival and enhance treatment decisions for
patients with liver metastatic colorectal cancer by using on-treatment radiomics signature to …

Radiomics Response Signature for Identification of Metastatic Colorectal Cancer Sensitive to Therapies Targeting EGFR Pathway.

L Dercle, L Lu, LH Schwartz, M Qian… - Journal of the …, 2020 - dial.uclouvain.be
BACKGROUND: The authors sought to forecast survival and enhance treatment decisions
for patients with liver metastatic colorectal cancer by using on-treatment radiomics signature …

Radiomics Response Signature for Identification of Metastatic Colorectal Cancer Sensitive to Therapies Targeting EGFR Pathway.

L Dercle, L Lu, LH Schwartz, M Qian… - Journal of the …, 2020 - europepmc.org
Background The authors sought to forecast survival and enhance treatment decisions for
patients with liver metastatic colorectal cancer by using on-treatment radiomics signature to …